Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer Immunomics

1 Jun 2007

Abstract excerpt

Cancer remains one of the leading causes of death worldwide. Thus, to identify any useful biomarkers is still a need. We performed "cancer immunomics" to identify autoantibody signatures produced in response to the presence of either breast or colorectal cancer. SERological proteome analysis (SERPA) was performed by two-dimensional (2-D) electrophoresis separation, immunoblotting, image analysis, and mass...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17804550
DOI: 10.1196/annals.1381.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer ImmunomicsPMID 17804550Read ↗

Identifying autoantibody signatures in cancer: a promising challengeSemantic proximity Read ↗

Seromic profiling of ovarian and pancreatic cancerSemantic proximity Read ↗

Tumor-associated Antigen Arrays for the Serological Diagnosis of CancerSemantic proximity Read ↗

Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseasesSemantic proximity Read ↗

Proteome Serological Determination of Tumor-Associated Antigens in MelanomaSemantic proximity Read ↗

High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypesSemantic proximity Read ↗

Proteome analysis and its impact on the discovery of serological tumor markersSemantic proximity Read ↗

Tumor-associated autoantibodies as diagnostic and prognostic biomarkersSemantic proximity Read ↗

The Sentinel Within: Exploiting the Immune System for Cancer BiomarkersSemantic proximity Read ↗

Development of Natural Protein Microarrays for Diagnosing Cancer Based on an Antibody Response to Tumor AntigensSemantic proximity Read ↗

Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profilingSemantic proximity Read ↗

Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein MicroarraysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.